Changing landscape of optical imaging in skeletal metastases
Optical imaging is an emerging strategy for in vitro and in vivo visualization of the molecular mechanisms of cancer over time. An increasing number of optical imaging contrast agents and techniques have been developed in recent years specifically for bone research and skeletal metastases. Visualizi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | Journal of Bone Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137419300703 |
id |
doaj-5401c0b13cc84e2084d79538698bee1d |
---|---|
record_format |
Article |
spelling |
doaj-5401c0b13cc84e2084d79538698bee1d2020-11-25T01:59:25ZengElsevierJournal of Bone Oncology2212-13742019-08-0117Changing landscape of optical imaging in skeletal metastasesNicholas Cho0Monica Shokeen1Department of Radiology, Washington University School of Medicine, 4515 McKinley Ave, St. Louis, MO 63110, United States; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63110, United StatesDepartment of Radiology, Washington University School of Medicine, 4515 McKinley Ave, St. Louis, MO 63110, United States; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63110, United States; Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, MO 63110, United States; Corresponding author at: Department of Radiology, Washington University School of Medicine, 4515 McKinley Ave, St. Louis, MO 63110, United StatesOptical imaging is an emerging strategy for in vitro and in vivo visualization of the molecular mechanisms of cancer over time. An increasing number of optical imaging contrast agents and techniques have been developed in recent years specifically for bone research and skeletal metastases. Visualizing molecular processes in relation to bone remodeling in metastasized cancers provides valuable information for understanding disease mechanisms and monitoring expression of primary molecular targets and therapeutic efficacy. This review is intended to provide an overview of tumor-specific and non-specific contrast agents in the first near-infrared window (NIR-I) window from 650 nm to 950 nm that can be used to study functional and structural aspects of skeletal remodeling of cancer in preclinical animal models. Near-infrared (NIR) optical imaging techniques, specifically NIR spectroscopy and photoacoustic imaging, and their use in skeletal metastases will also be discussed. Perspectives on the promises and challenges facing this exciting field are then given. Keywords: Metastases, Near-infrared (NIR) fluorescence, Spectroscopy, Raman, Photoacoustic tomography (PAT), Bonehttp://www.sciencedirect.com/science/article/pii/S2212137419300703 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nicholas Cho Monica Shokeen |
spellingShingle |
Nicholas Cho Monica Shokeen Changing landscape of optical imaging in skeletal metastases Journal of Bone Oncology |
author_facet |
Nicholas Cho Monica Shokeen |
author_sort |
Nicholas Cho |
title |
Changing landscape of optical imaging in skeletal metastases |
title_short |
Changing landscape of optical imaging in skeletal metastases |
title_full |
Changing landscape of optical imaging in skeletal metastases |
title_fullStr |
Changing landscape of optical imaging in skeletal metastases |
title_full_unstemmed |
Changing landscape of optical imaging in skeletal metastases |
title_sort |
changing landscape of optical imaging in skeletal metastases |
publisher |
Elsevier |
series |
Journal of Bone Oncology |
issn |
2212-1374 |
publishDate |
2019-08-01 |
description |
Optical imaging is an emerging strategy for in vitro and in vivo visualization of the molecular mechanisms of cancer over time. An increasing number of optical imaging contrast agents and techniques have been developed in recent years specifically for bone research and skeletal metastases. Visualizing molecular processes in relation to bone remodeling in metastasized cancers provides valuable information for understanding disease mechanisms and monitoring expression of primary molecular targets and therapeutic efficacy. This review is intended to provide an overview of tumor-specific and non-specific contrast agents in the first near-infrared window (NIR-I) window from 650 nm to 950 nm that can be used to study functional and structural aspects of skeletal remodeling of cancer in preclinical animal models. Near-infrared (NIR) optical imaging techniques, specifically NIR spectroscopy and photoacoustic imaging, and their use in skeletal metastases will also be discussed. Perspectives on the promises and challenges facing this exciting field are then given. Keywords: Metastases, Near-infrared (NIR) fluorescence, Spectroscopy, Raman, Photoacoustic tomography (PAT), Bone |
url |
http://www.sciencedirect.com/science/article/pii/S2212137419300703 |
work_keys_str_mv |
AT nicholascho changinglandscapeofopticalimaginginskeletalmetastases AT monicashokeen changinglandscapeofopticalimaginginskeletalmetastases |
_version_ |
1724964656442769408 |